Literature DB >> 3289683

Expression of ETS proto-oncogenes in astrocytes in human cortex.

P Amouyel1, A Gégonne, A Delacourte, A Défossez, D Stéhelin.   

Abstract

In order to investigate a possible function of ETS proto-oncogenes in human brain, we incubated a polyclonal antibody raised against the viral region of E26 homologous to ETS1 and ETS2 with human brain frontal cortex sections. Our results show that this antibody decorates astrocytes but not neurons. By using astrocytomas of different grades as a source of astrocytes, we demonstrate the presence of ETS1 and ETS2 messenger RNAs and proteins. This leads to the idea that ETS genes are expressed in cells with dividing potentialities in human cortex and that they could provide a new marker for glial cells. Recently, a microduplication on chromosome 21 including ETS2 locus was described in karyotypically 'normal' Down's syndrome and suspected in Alzheimer's disease; when testing Alzheimer's disease-affected brain cortex sections, no obvious difference was observed with the technique used.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3289683     DOI: 10.1016/0006-8993(88)90976-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.

Authors:  N Wernert; M B Raes; P Lassalle; M P Dehouck; B Gosselin; B Vandenbunder; D Stehelin
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

2.  Direct and indirect mechanisms of repression participate in suppression of T-cell-specific gene expression in T x L-cell hybrids.

Authors:  L Shurman; R Laskov; Y Bergman
Journal:  Gene Expr       Date:  1996

3.  Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1.

Authors:  N K Bhat; C B Thompson; T Lindsten; C H June; S Fujiwara; S Koizumi; R J Fisher; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

4.  Molecular and functional characterization of the promoter of ETS2, the human c-ets-2 gene.

Authors:  G J Mavrothalassitis; D K Watson; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  ETS1 suppresses tumorigenicity of human colon cancer cells.

Authors:  H Suzuki; V Romano-Spica; T S Papas; N K Bhat
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

6.  ets-1 in astrocytes: expression and transmitter-evoked phosphorylation.

Authors:  L F Fleischman; L Holtzclaw; J T Russell; G Mavrothalassitis; R J Fisher
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

7.  Expression of the Ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasion.

Authors:  T Nakayama; M Ito; A Ohtsuru; S Naito; M Nakashima; J A Fagin; S Yamashita; I Sekine
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

8.  The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation.

Authors:  I Kola; S Brookes; A R Green; R Garber; M Tymms; T S Papas; A Seth
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

9.  VARAdb: a comprehensive variation annotation database for human.

Authors:  Qi Pan; Yue-Juan Liu; Xue-Feng Bai; Xiao-Le Han; Yong Jiang; Bo Ai; Shan-Shan Shi; Fan Wang; Ming-Cong Xu; Yue-Zhu Wang; Jun Zhao; Jia-Xin Chen; Jian Zhang; Xue-Cang Li; Jiang Zhu; Guo-Rui Zhang; Qiu-Yu Wang; Chun-Quan Li
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

10.  Reverse Pathway Genetic Approach Identifies Epistasis in Autism Spectrum Disorders.

Authors:  Ileena Mitra; Alinoë Lavillaureix; Erika Yeh; Michela Traglia; Kathryn Tsang; Carrie E Bearden; Katherine A Rauen; Lauren A Weiss
Journal:  PLoS Genet       Date:  2017-01-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.